PHILADELPHIA--(BUSINESS WIRE)--Today Siemens Healthineers unveiled the Atellica™ Solution,1 a highly flexible immunoassay and clinical chemistry solution featuring patented bi-directional magnetic sample-transport technology that is 10 times faster than conventional conveyors.1 The unveiling occurred during the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia, July 31 – August 4 (booth 2101).
“We engineered the Atellica Solution1 based on our customers’ needs and extensive research of market trends,” said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers. “The result is a game-changer that delivers control and simplicity, so our customers can focus on driving better business and clinical outcomes and spend less time managing operations.”
In addition to the speed afforded by the Atellica Magline™ Transport technology,1 the Atellica Solution1 offers a multi-camera vision system1 and intelligent sample routing1 for independent control over every sample from routines to STATs.
The Atellica Solution1 provides unprecedented flexibility to adapt to growing testing needs and space constraints. The solution can be used as a stand-alone system, is scalable up to 10 components and can be combined into more than 300 customizable configurations,1 including L-shaped, U-shaped, and linear formations. It can also be connected to Aptio® Automation for a comprehensive multidisciplinary solution.1 The solution can handle more than 30 sample container types including pediatric and special containers.
Further, the same reagents can be used across configurations and locations, simplifying laboratory operations, streamlining inventory control, and enabling consistent testing results. Additionally, a single immunoassay analyzer processes more than 400 tests per hour,3 delivering the highest productivity per square meter in the industry.2
Other benefits of the Atellica Solution1 include remote-access monitoring and control1 to maximize uptime, and a broad, expanding assay menu1 using proven detection technologies.
The Atellica Solution1 is the first in a new line of Atellica products engineered by Siemens Healthineers and further innovations are in the R&D pipeline.
1 Products are under FDA review. Not available for sale. Any features listed are part of the development design goals. Future availability cannot be guaranteed.
2 Versus leading IVD market competitors.
3 Dependent upon test mix.
For further information on Siemens Healthineers, please see www.healthcare.siemens.com.
For further information on the Atellica Solution and other Siemens Healthineers products being exhibited at AACC, please see www.siemens.com/aacc.
Follow us on Twitter at: www.twitter.com/SiemensHealth
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world’s largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of gas and steam turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2015, which ended on September 30, 2015, Siemens generated revenue of €75.6 billion and net income of €7.4 billion. At the end of September 2015, the company had around 348,000 employees worldwide. Further information is available on the Internet at www.siemens.com
